Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model
- PMID: 31793435
- PMCID: PMC6890461
- DOI: 10.7554/eLife.49920
Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model
Abstract
Chronic critical illness is a global clinical issue affecting millions of sepsis survivors annually. Survivors report chronic skeletal muscle weakness and development of new functional limitations that persist for years. To delineate mechanisms of sepsis-induced chronic weakness, we first surpassed a critical barrier by establishing a murine model of sepsis with ICU-like interventions that allows for the study of survivors. We show that sepsis survivors have profound weakness for at least 1 month, even after recovery of muscle mass. Abnormal mitochondrial ultrastructure, impaired respiration and electron transport chain activities, and persistent protein oxidative damage were evident in the muscle of survivors. Our data suggest that sustained mitochondrial dysfunction, rather than atrophy alone, underlies chronic sepsis-induced muscle weakness. This study emphasizes that conventional efforts that aim to recover muscle quantity will likely remain ineffective for regaining strength and improving quality of life after sepsis until deficiencies in muscle quality are addressed.
Keywords: chronic critical illness; critical illness myopathy; human biology; immunology; inflammation; medicine; mitochondria; mouse; muscle; post-intensive care syndrome; sepsis.
© 2019, Owen et al.
Conflict of interest statement
AO, SP, JS, BB, SM, GH, AS, NK, MK, AR, TB, KE, CP, MS, HS No competing interests declared
Figures
Comment in
-
Modelling survival.Elife. 2019 Dec 10;8:e52959. doi: 10.7554/eLife.52959. Elife. 2019. PMID: 31821147 Free PMC article.
References
-
- Bierbrauer J, Koch S, Olbricht C, Hamati J, Lodka D, Schneider J, Luther-Schröder A, Kleber C, Faust K, Wiesener S, Spies CD, Spranger J, Spuler S, Fielitz J, Weber-Carstens S. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Critical Care Medicine. 2012;40:647–650. doi: 10.1097/CCM.0b013e31823295e6. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- F31 GM117868/GM/NIGMS NIH HHS/United States
- R01 GM115552/GM/NIGMS NIH HHS/United States
- R01 GM117298/GM/NIGMS NIH HHS/United States
- R01 AG039732/AG/NIA NIH HHS/United States
- P30 AG028740/AG/NIA NIH HHS/United States
- P30 CA177558/CA/NCI NIH HHS/United States
- R01 AR066082/AR/NIAMS NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- P20 GM103527/GM/NIGMS NIH HHS/United States
- R01 GM129532/GM/NIGMS NIH HHS/United States
- R01 GM126181/GM/NIGMS NIH HHS/United States
- R01 AG390732/AG/NIA NIH HHS/United States
- R01 AG055359/AG/NIA NIH HHS/United States
- UL1 TR001998/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
